Daily Anesthesiology Research Analysis
Analyzed 67 papers and selected 3 impactful papers.
Summary
Top advances span mechanistic neurophysiology, critical care guidance, and perioperative kidney protection. Simultaneous EEG-SEEG mapping reveals distinct low- and high-alpha generators that shift with anesthetic depth, redefining EEG biomarkers of consciousness. New SCCM guidelines conditionally recommend neuromuscular blockade in moderate-to-severe ARDS, while a pediatric perioperative study identifies a plasma NGAL cutoff and mean arterial pressure thresholds linked to kidney injury.
Research Themes
- Anesthesia neurophysiology and consciousness biomarkers
- Evidence-based use of neuromuscular blockade in ARDS
- Perioperative kidney injury biomarkers and hemodynamic thresholds
Selected Articles
1. Distinct origins of human low and high alpha rhythms revealed by simultaneous EEG-SEEG.
Simultaneous EEG-SEEG revealed a state-dependent shift from an occipital low-alpha (8–10 Hz) rhythm during eyes-closed wakefulness to a globally distributed high-alpha (10–13 Hz) rhythm at anesthetic-induced loss of consciousness. Changes were driven by periodic components rather than aperiodic activity and were captured by a simple dynamical model. Findings redefine alpha-band biomarkers pertinent to anesthesia depth and consciousness.
Impact: Provides first direct human evidence for distinct generators of low- vs high-alpha rhythms and their anesthetic modulation. This advances mechanistic understanding critical for refining EEG-based depth-of-anesthesia and consciousness metrics.
Clinical Implications: May inform next-generation EEG monitors to distinguish alpha sub-bands and track state transitions, improving detection of anesthetic depth and possibly avoiding awareness. Offers modeling targets for anesthesia–brain interaction.
Key Findings
- Occipital low-alpha (8–10 Hz) dominates during eyes-closed wakefulness and diminishes with increasing anesthetic depth.
- A globally distributed high-alpha (10–13 Hz) emerges at loss of consciousness under anesthesia, replacing low-alpha.
- Alpha-band shifts are driven by periodic activity changes rather than aperiodic 1/f components and are reproduced by a simple dynamical model.
Methodological Strengths
- Simultaneous intracranial SEEG and scalp EEG across 32 brain regions capturing local and global dynamics.
- State-resolved recording from wakefulness to anesthetic-induced loss of consciousness with modeling of periodic vs aperiodic components.
Limitations
- Exact participant number and anesthetic agent dosing details were not specified in the abstract.
- SEEG cohorts are typically limited to specific clinical populations, which may constrain generalizability.
Future Directions: Validate alpha sub-band biomarkers across agents and populations; integrate into real-time EEG monitors; correlate with behavioral responsiveness and postoperative outcomes.
Alpha-band activity is the most prominent neurobiological feature of scalp electroencephalography (EEG) signals, recent findings showed that there is more than one alpha rhythm coexisted in this 8-13 Hz band, but the generation mechanism of them was not fully understood. To address this question, we collected local field potential (LFP) in 32 brain regions of human brain with stereo-EEG (SEEG), with simultaneously recording with EEG during the process from awaked state (eyes-closed) to loss of consciousness (LOC) state with anesthesia. Our
2. Society of Critical Care Medicine Guidelines for the Administration of Neuromuscular Blockade in Adults With Acute Respiratory Distress Syndrome.
A multidisciplinary SCCM panel using GRADE issued conditional recommendations: use NMBA in adults with ARDS when PaO2/FiO2 <150, while evidence is insufficient to favor titratable versus fixed dosing, sedation/analgesia monitoring strategies, or routine NMBA during proning. Emphasis is placed on patient- and institution-specific decision-making.
Impact: Provides up-to-date, evidence-based guidance on NMBA use in ARDS, an area of high clinical controversy and importance for anesthesiology and critical care teams.
Clinical Implications: For adults with ARDS and PaO2/FiO2 <150, teams should consider NMBA use with appropriate sedation and monitoring, while tailoring dosing approaches and use during proning based on local expertise, resources, and patient safety.
Key Findings
- Conditional recommendation to use NMBAs in adults with ARDS when PaO2/FiO2 <150.
- Insufficient evidence to recommend titratable versus fixed-dose NMBA strategies.
- Equipoise regarding sedation/analgesia depth monitoring strategies and NMBA use during proning due to safety and evidence gaps.
Methodological Strengths
- GRADE-based systematic reviews with multidisciplinary expert panel and explicit evidence-to-decision framework.
- Strict conflict-of-interest management throughout development.
Limitations
- Predominantly conditional recommendations reflecting limited or heterogeneous evidence base.
- Guideline recommendations may require adaptation to local contexts and resources.
Future Directions: High-quality RCTs comparing dosing strategies, standardized sedation monitoring approaches, and evaluating NMBA use during proning are needed.
RATIONALE: Neuromuscular blocking agents (NMBAs) show potential benefits on mortality and other complications of acute respiratory distress syndrome (ARDS) in adult patients. Evidence-based decisions and processes ensure appropriate use of neuromuscular blockade in adult patients with ARDS. OBJECTIVES: The objective of these guidelines was to develop evidence-based recommendations for the administration of NMBAs in critically ill adult patients with ARDS. DESIGN: The American College of Critical Care Medicine Board convened a 21-member multidisciplinary panel of experts in critical care medicine, nursing, respiratory therapy, pharmacology, surgery, neurology, and anesthesiology. The panel included two expert methodologists specialized in developing evidence-based recommendations in alignment with the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) methodology. Conflict-of-interest policies were strictly followed during all phases of guidelines development including task force selection and voting. METHODS: The panel members identified and formulated five Population, Intervention, Comparison, and Outcome questions. We conducted a systematic review for each question to identify the best available evidence, statistically analyzed the evidence, and assessed the certainty of the evidence using the GRADE methodology. We used the GRADE evidence-to-decision framework to formulate the recommendations. RESULTS: The panel generated two conditional recommendations. One recommendation is to use NMBAs in adults with ARDS with Pao2/Fio2 less than 150. For the other recommendations, there was equipoise in the recommendation for and against using titratable vs. fixed-dose NMBA dosing, a monitoring-based strategy for assessing depth of sedation and analgesia in adults with ARDS before initiating or while receiving neuromuscular blockade, and administration of NMBAs for patients who are proned, due to overall lack of evidence in critically ill patients and due to considerations of patient safety and experience concerns. CONCLUSIONS: These guidelines provide additional perspectives on the use of NMBA in patients with ARDS, recognizing that institutional and patient-specific considerations must help to guide the decision-making process.
3. Plasma NGAL-detected kidney injury following paediatric spine surgery: role of intraoperative hypotension.
In 66 children undergoing posterior spinal instrumentation, clinical AKI occurred in 12%, while 31.8% had subclinical AKI detectable only by plasma NGAL. A 6-hour NGAL threshold of 86 ng/mL (AUC 0.817; sensitivity 100%) predicted AKI. Intraoperative hypotension was independently associated with kidney injury: MAP <70 mmHg related to tubular damage and MAP <60 mmHg to clinical AKI.
Impact: Defines an actionable NGAL cutoff and MAP thresholds in pediatric non-cardiac surgery, enabling earlier detection and targeted hemodynamic management to mitigate AKI.
Clinical Implications: In pediatric spine surgery, consider measuring plasma NGAL at 6 hours post-induction and avoid sustained MAP <70 mmHg, with particular vigilance to prevent MAP <60 mmHg, to reduce tubular injury and clinical AKI.
Key Findings
- Clinical AKI incidence was 12%, while 31.8% had NGAL-defined subclinical AKI.
- Plasma NGAL at 6 hours predicted AKI with a cutoff of 86 ng/mL (AUC 0.817; sensitivity 100%; specificity 63.8%).
- Longer durations of intraoperative MAP <70 and <65 mmHg associated with kidney injury; MAP <60 mmHg specifically associated with clinical AKI.
Methodological Strengths
- Prospective design with serial biomarker sampling at predefined perioperative timepoints.
- Multivariable analyses linking physiologic thresholds (MAP) with both clinical and subclinical AKI phenotypes.
Limitations
- Single-center study with modest sample size limits generalizability and external validity of cutoffs.
- NGAL specificity was moderate; clinical integration requires validation and protocol development.
Future Directions: External validation of NGAL cutoff and MAP thresholds, integration into perioperative goal-directed hemodynamic protocols, and testing biomarker-guided AKI prevention strategies.
BACKGROUND: Post-operative acute kidney injury (AKI) remains a major complication in paediatric surgery. Serum creatinine is an insensitive marker, that increases only after significant impairment. Neutrophil gelatinase-associated lipocalin (NGAL) has emerged as an early biomarker capable of detecting tubular injury before functional decline. This study aimed to determine the incidence of clinical AKI and subclinical AKI in paediatric spine surgery using plasma NGAL levels and to evaluate the associations of intraoperative hypotension with kidney injury. METHODS: In this prospective single-centre study, 66 children (mean age 15.2 ± 1.7 years) who underwent elective posterior spinal instrumentation were enrolled. Plasma NGAL was measured after induction (T1, baseline), and subsequently at 6 and 24 h after induction (T2 and T3, respectively). Clinical AKI was defined by the KDIGO criteria. ROC analysis was used to determine NGAL cut-off values; patients with NGAL above the the cut-off but without KDIGO-AKI were classified as having subclinical AKI. Potential risk factors, particularly intraoperative hypotension, were analysed. RESULTS: Clinical AKI occurred in 12% of patients. The NGAL-T2 cut-off for AKI was 86 ng/mL (AUC = 0.817; sensitivity = 100%; specificity = 63.8%). Twenty-nine patients exceeded this cut off; 8 developed clinical AKI and 21 (31.8%) had subclinical AKI. In multivariable analyses, intraoperative hypotension exposure remained independently associated with kidney injury. Durations of MAP < 70 and < 65 mmHg were significantly longer in the clinical AKI and subclinical AKI groups than in the non-AKI group, whereas time spent below MAP < 60 mmHg was significantly prolonged only in the clinical AKI group compared with both the subclinical AKI and non-AKI groups. CONCLUSIONS: Although 12% of the children developed clinical AKI, approximately one-third had subclinical AKI detectable only by NGAL. Plasma NGAL at the 6th hour demonstrated excellent sensitivity for predicting AKI, with a threshold of 86 ng/mL. Intraoperative hypotension was a major predictor, with a MAP < 70 mmHg linked to tubular damage whereas deeper hypotension (MAP < 60 mmHg) was linked to clinical AKI. This study is the first to define NGAL cut-off values and intraoperative MAP thresholds for postoperative AKI in paediatric non-cardiac surgery.